J. Mourik

发表

The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes

K. Mertens, J. Holthuis, J. A. Mourik, 1994, British journal of haematology.

Ca v 3.1 ( α 1G ) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells

Wu, Y. Xi, J. Ju, 2011 .

Cav 3 . 1 ( 1 G ) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells

Y. Xi, J. Ju, J. A. Mourik, 2007 .

Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.

H. Lambers, P. Diergaarde, H. Pannekoek, 1986, The EMBO journal.

A mutation in the gene encoding the α2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2)

E. Mariman, B. Olsen, M. Warman, 1996, Nature Genetics.

Promotion of endothelial coverage and decrease of platelet reactivity of artificial surfaces using monoclanal antibodies directed against endothelial cells

J. Feijen, A. Poot, A. Bantjes, 1991 .

The role of cellular fibronectin in the interaction of human endothelial cells with polymers

J. Feijen, A. Poot, A. Bantjes, 1993 .

Dependence of Endothelial Cell Growth on Substrate-Bound Fibronectin

J. Feijen, A. Poot, A. Bantjes, 1992 .

Von Willebrand Factor in Cultured Human Vascular Endothelial Cells from Adult and Umbilical Cord Arteries and Veins

P. Groot, J. Mourik, W. Aken, 1986, Thrombosis and Haemostasis.

Binding and inactivation of prostacyclin (PGI2) by human erythrocytes

H. V. Stel, C. Willems, J. Mourik, 1983, British journal of haematology.

What Is the Theoretical Basis for the Therapeutic Use of Cryoprecipitates as a Source of Fibronectin?

J. E. Doran, D. Mosher, F. Blumenstock, 1985, Vox sanguinis.

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

J. Voorberg, K. Mertens, J. A. Mourik, 1994, The Lancet.

Biosynthesis, processing and secretion of von Willebrand factor: biological implications.

J. A. Mourik, T. R. Wit, J. Mourik, 2001 .

Biological activity of recombinant factor VIII variants lacking the central B‐domain and the heavy‐chain sequence Lys713‐Arg740: discordant in vitro and in vivo activity

M. Verbeet, K. Mertens, A. Leyte, 1993, British journal of haematology.

Factor‐VIII Antigen and Platelet Retention in a Glass Bead Column

J. Sixma, J. A. Mourik, B. Bouma, 1973, British journal of haematology.

Rheumatoid Arthritis-Evidence for Dephosphorylation and Garboxyterminal Degradation of the Peptide by the Kidney

F., E., O. Leeksma, 2018 .

The platelet glycoprotein Ia‐IIa‐associated Br‐alloantigen system is expressed by cultured endothelial cells

A. Borne, V. Kiefel, H. Brinkman, 1990, British journal of haematology.

Effect of the Binding of Anti‐Zwa Antibodies on Platelet Function

O. Leeksma, C. Engelfriet, A. Borne, 1984, Vox sanguinis.

Expression of the alloantigen Zwa (or P1A1) on human vascular smooth muscle cells and foreskin fibroblasts: a study on normal individuals and a patient with Glanzmann's thrombasthenia

J. A. Mourik, A. V. D. Borne, H. Brinkman, 1989 .

Pathophysiological Significance of Endothelial Cell Integrins

J. A. Mourik, A. V. D. Borne, J. Giltay, 1991 .

Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex

J. A. Mourik, A. V. D. Borne, P. Modderman, 1989 .

Cellular Distribution and Heterogeneity of Endothelial Cell Adhesion Receptors

J. A. Mourik, A. V. D. Borne, J. Giltay, 1989 .

Membrane glycoproteins of endothelial cells and platelets

O. Leeksma, J. Zandbergen-Spaargaren, J. Giltay, 1987 .

Alloantigenic Composition of the Endothelial Vitronectin Receptor 230 Blood

O. Leeksma, J. A. Mourik, J. Giltay, 2005 .

Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization.

J. Voorberg, H. Pannekoek, J. A. Mourik, 1990, The EMBO journal.

The proliferation of human umbilical vein endothelial cells in serum-free medium

C. Willems, M. Gonsalves, J. Mourik, 1983 .

Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes

M. Zelechowska, J. A. Mourik, T. Brodniewicz-Proba, 1985, Nature.

Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium

J. Sixma, B. Scholte, E. Veerman, 1984 .

Cysteine‐mutations in von Willebrand factor associated with increased clearance

P. Lenting, C. Denis, R. Bertina, 2005, Journal of thrombosis and haemostasis : JTH.

A Monoclonal Antibody to the Human Platelet Glycoprotein II b/III a Complex Induces Platelet Activation

J. V. van Mourik, A. von dem Borne, P. Modderman, 1988, Thrombosis and Haemostasis.

CD18, ELAM-1, and VLA-4 of monolayers of cytokine-activated endothelial cells: the contribution Neutrophil and monocyte adherence to and migration across

T. Kuijpers, J. Leeuwenberg, B. Hakkert, 2011 .

Rapid activation of endothelial cells enables P . falciparum adhesion to platelet decorated von Willebrand factor strings

A. Craig, M. Molyneux, G. Grau, 2010 .

Involvement of ELAM-1 in monocyte adherence to and migration across IL-1-stimulated endothelial cell monolayers

T. Kuijpers, W. Buurman, B. Hakkert, 1992 .

Endothelial cell dysfunction in homocystinuria

G. Boers, W. G. Aken, P. D. Groot, 1983, European journal of clinical investigation.

With von Willebrand Disease In Vivo Characterization of Recombinant von Willebrand Factor in Dogs

F. Dorner, P. Schwarz, B. Fischer, 2013 .

Involvement of Cyclooxygenase- and Lipoxygenase-Mediated Conversion of Arachidonic Acid in Controlling Human Vascular Smooth Muscle Cell Proliferation

H. Brinkman, J. Mourik, Marijke Buul-Worteiboer, 1990, Thrombosis and Haemostasis.

bodies from endothelial cells Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade

M. Rondaij, R. Bierings, J. Voorberg, 2013 .

Extra‐hepatic factor VIII expression in porcine fulminant hepatic failure

T. M. Gulik, P. Poyck, H. Marsman, 2005, Journal of thrombosis and haemostasis : JTH.

Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia

W. Ouwehand, A. Borne, C. Kaplan, 1989, British journal of haematology.

UvA-DARE ( Digital Academic Repository ) Factor VIII expression and regulation in health and disease

Link, P. Reitsma, J. Meijers, 2007 .

BIOSYNTHESIS AND ASSEMBLY OF VON WILLEBRAND FACTOR BY VASCULAR ENDOTHELIAL CELLS: RELEVANCE

J. A. Mourik, To Pathophysiology, J. Mourik, 1991 .

Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene

H. Pannekoek, A. Geurts van Kessel, C. L. Verweij, 1985, Nucleic Acids Res..

Chapte rr 4 Elevate dd plasm a facto r VIM level s in anhepati c pig s s

P. Poyck, H. Marsman, T. Gulik, 2007 .

Optimization of the interaction between ethylenevinyl alcohol copolymers and human endothelial cells

S. Martinoia, A. Ahluwalia, M. Grattarola, 1996 .

Polyclonal B Lymphocytosis? Identity Between Hairy B-Cell Lymphoproliferative Disorder and Persistent

J. Mourik, 1997 .

Biogenesis of von Willebrand factor‐containing organelles in heterologous transfected CV‐1 cells.

J. Voorberg, J. Calafat, H. Janssen, 1993, The EMBO journal.

outcomewith cerebral ischaemic events and markers in aneurysmal subarachnoid haemorrhage: Early circulating levels of endothelial cell activation

A. Algra, C. Frijns, G. Rinkel, 2006 .

Biosynthesis and assembly of the factor VIII-von Willebrand factor complex

J. Voorberg, M. Verbeet, H. Pannekoek, 1990 .

Arterial and venous thrombosis in two Italian families with the factor V Arg506→ Gln mutation

J. Voorberg, G. Muleo, J. A. Mourik, 1996, European journal of haematology.

Chapter 5 VON WILLEBRAND FACTOR PROPEPTIDE IN VASCULAR DISORDERS

J. A. Mourik, T. R. Wit, J. Mourik, 2003 .

Factor VIII expression and regulation in health and disease

A. Craig, O. Akoto, M. J. Hollestelle, 2004 .

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts.

J. V. van Mourik, P. O’Connell, M. Letarte, 1992, International immunology.

The life cycle of coagulation factor VIII in view of its structure and function.

P. Lenting, J. V. van Mourik, K. Mertens, 1998, Blood.

Intracellular accumulation of factor VIII induced by missense mutations Arg593→Cys and Asn618→Ser explains cross‐reacting material‐reduced haemophilia A

J. Voorberg, Roelse, De Laaf, 2000, British journal of haematology.

The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.

J. T. ten Cate, J. V. van Mourik, J. Voorberg, 1997, Blood.

Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor.

C. Niehrs, W. Huttner, J. V. van Mourik, 1991, The Journal of biological chemistry.

Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.

P. Lenting, J. V. van Mourik, K. Mertens, 1996, European journal of biochemistry.

Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C.

P. D. de Groot, J. V. van Mourik, C. van ′t Veer, 1993, The Journal of biological chemistry.

Current practise of testing for inherited thrombophilia

H. Büller, J. V. van Mourik, S. Middeldorp, 2007, Journal of thrombosis and haemostasis : JTH.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation

P. V. van Genderen, J. V. van Mourik, D. Pajkrt, 1999 .

The uptake and expression of the factor VIII and reporter genes by vascular cells

J. V. van Mourik, J. M. Bos, J. T. Powell, 1992, FEBS letters.

A Mutation in COL9A2 Causes Multiple Epiphyseal Dysplasia (EDM2)

E. Mariman, B. Olsen, M. Warman, 1996, Annals of the New York Academy of Sciences.

Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura

J. V. van Mourik, J. Voorberg, J. K. Kremer Hovinga, 2006, Journal of thrombosis and haemostasis : JTH.

Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII.

P. Lenting, J. V. van Mourik, K. Mertens, 1994, The Journal of biological chemistry.

Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain.

J. Sixma, J. V. van Mourik, R. Bertina, 1987, European journal of biochemistry.

In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease.

J. V. van Mourik, F. Dorner, H. Schwarz, 1997, Blood.

ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock

B. Lämmle, P. Reitsma, C. Hack, 2007, Journal of thrombosis and haemostasis : JTH.

Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1.

R. van Wijk, P. D. de Groot, J. V. van Mourik, 1985, Experimental cell research.

Biosynthesis, processing and secretion of von Willebrand factor: biological implications.

T. R. Wit, J. Mourik, 2001, Best practice & research. Clinical haematology.

Chapter 7 VON WILLEBRAND FACTOR PROPEPTIDE ENHANCES IL-8-INDUCED NEUTROPHIL ADHESION

T. R. Wit, J. Mourik, 2003 .

Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome

A. Algra, C. Frijns, J. V. van Mourik, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation

D. Pajkrt, K. Fijnvandraat, R. Fijnheer, 1999 .

Review : Factor V Arg506 → Gln mutation in patients with antiphospholipid antibodies

J. V. van Mourik, J. Voorberg, A. Borchiellini, 1996, Lupus.

Fibrinopeptide A in Urine from Patients with Venous Thromboembolism, Disseminated Intravascular Coagulation and Rheumatoid Arthritis - Evidence for Dephosphorylation and Carboxyterminal Degradation of the Peptide by the Kidney

J. V. van Mourik, W. van Aken, O. Leeksma, 1985, Thrombosis and Haemostasis.

Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.

J. Sixma, P. D. de Groot, J. V. van Mourik, 1984, The Journal of clinical investigation.

Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.

J. Sixma, J. V. van Mourik, B. Bouma, 1972, Nature: New biology.